Navigation auf uzh.ch
Project title/PI | Discovery (D), Evaluation (E), Implementation (I) | Link to project page |
---|---|---|
1 Minute Sit-to-Stand Test in Cystic Fibrosis
|
D, E | More… |
Benefit-harm assessments to inform patient-centered care for older people with multiple chronic conditions |
D, E | More… |
COGEN |
D, E, I | More… |
Hospital and nursing home stays in Switzerland
Matthias Bopp |
E, I | More… |
Immunological Correlates of COVID-19 Severity |
D, E | More… |
Impact of the matching algorithm on the treatment effect estimate: A neutral comparison study Ulrike Held / Priska Heinz |
D, E | More… |
Model-Based Recursive Partitioning for Stratified Medicine
|
D, E, I | More… |
PCORI: Benefit harm assessment methods for guidelines |
D, E, I | More… |
Prognostic models for predicting clinical disease progression, worsening and activity in people with multiple sclerosis
|
E | More… |
SEDA: Sensitivity diagnostics for Bayesian hierarchical models |
D, E, I | More… |
Strengths and Limits of Swiss Health Statistics
Matthias Bopp |
E | More… |
SURFit: Effects of a 1-year partially supervised exercise programme in childhood cancer survivors – a randomized controlled trial
|
D, E | More… |
Swiss MS Registry - Registry Development
|
D, E, I | More… |
Swiss National Cohort
Matthias Bopp |
D, E | More… |
The OVID trial was initiated in 2020, at the beginning of the pandemic, with the aim to demonstrate superiority of enoxaparin as compared to standard of care for primary thromboprophylaxis in ambulatory patients with coronavirus disease
|
D | More… |